Empirical Wealth Management’s Revolution Medicines RVMD Stock Holding History

Empirical Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	+1,253	New	+$183K	﹤0.01%	965

Other funds holding RVMD

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Empirical Wealth Management's RVMD Position: Q2 2026 in Review

Empirical Wealth Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,253 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #965 among its holdings.

169 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Empirical Wealth Management held 1,253 shares of Revolution Medicines worth $235K as of Q2 2026.
Revolution Medicines was a new Empirical Wealth Management position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #965 holding.
169 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.